Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.57 USD | +14.73% |
|
+12.72% | +11.26% |
Jun. 26 | Oramed Pharmaceuticals Board Approves $20 Million Share-Buyback Program | MT |
Jun. 26 | Oramed Pharmaceuticals Inc. announces an Equity Buyback for $20 million worth of its shares. | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.26% | 104M | |
+23.13% | 46.93B | |
+37.83% | 39.08B | |
-8.73% | 38.48B | |
+28.09% | 31.01B | |
-12.26% | 26.14B | |
+10.57% | 25.88B | |
+45.05% | 14.15B | |
+32.23% | 12.53B | |
-6.56% | 11.36B |
- Stock Market
- Equities
- ORMP Stock
- News Oramed Pharmaceuticals Inc.
- Oramed Pharmaceuticals Inc. Announces Resignation of Avraham Gabay as Chief Financial Officer, Effective July 5, 2021